Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Mithoefer

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The American Journal of Psychiatry|January 1, 2024
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and NecessaryMichael D Alpert, Kelley C O'Donnell, Casey A Paleos, et al.
Psychopharmacology|August 10, 2024
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trialsMichael C Mithoefer, Allison A Feduccia, Lisa Jerome, et al.
Journal of Psychopharmacology (Oxford, England)|November 23, 2012
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
The Lancet. Psychiatry|May 6, 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trialMichael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, et al.
European Journal of Psychotraumatology|January 7, 2021
MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trialCandice M Monson, Anne C Wagner, Ann T Mithoefer, et al.
Journal of Psychopharmacology (Oxford, England)|October 30, 2018
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trialMarcela Ot'alora G, Jim Grigsby, Bruce Poulter, et al.
Scientific Reports|November 25, 2020
MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot studyPhilip E Wolfson, Julane Andries, Allison A Feduccia, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|July 9, 2020
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in BrazilAlvaro V Jardim, Dora V Jardim, Bruno Rasmussen Chaves, et al.
Journal of Psychopharmacology (Oxford, England)|June 10, 2025
A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapyTorsten Passie, Anja Loizaga-Velder, Alicia Danforth, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The American Journal of Psychiatry|January 1, 2024
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and NecessaryMichael D Alpert, Kelley C O'Donnell, Casey A Paleos, et al.
Psychopharmacology|August 10, 2024
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trialsMichael C Mithoefer, Allison A Feduccia, Lisa Jerome, et al.
Journal of Psychopharmacology (Oxford, England)|November 23, 2012
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
The Lancet. Psychiatry|May 6, 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trialMichael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, et al.
European Journal of Psychotraumatology|January 7, 2021
MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trialCandice M Monson, Anne C Wagner, Ann T Mithoefer, et al.
Journal of Psychopharmacology (Oxford, England)|October 30, 2018
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trialMarcela Ot'alora G, Jim Grigsby, Bruce Poulter, et al.
Scientific Reports|November 25, 2020
MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot studyPhilip E Wolfson, Julane Andries, Allison A Feduccia, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|July 9, 2020
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in BrazilAlvaro V Jardim, Dora V Jardim, Bruno Rasmussen Chaves, et al.
Journal of Psychopharmacology (Oxford, England)|June 10, 2025
A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapyTorsten Passie, Anja Loizaga-Velder, Alicia Danforth, et al.
Pageof 3